Holen Sie sich die Stockscreener-App
1.27
6.06%
0.05
Schlusskurs vom Vortag:
$1.32
Offen:
$1.3
24-Stunden-Volumen:
11,073
Relative Volume:
0.15
Marktkapitalisierung:
$2.33M
Einnahmen:
$2.00M
Nettoeinkommen (Verlust:
$-50.62M
KGV:
-0.0304
EPS:
-41.8255
Netto-Cashflow:
$-37.11M
1W Leistung:
+12.90%
1M Leistung:
-59.54%
6M Leistung:
-85.19%
1J Leistung:
-96.07%
1-Tages-Spanne:
$1.27
$1.45
1-Wochen-Bereich:
$1.265
$1.45
52-Wochen-Spanne:
$1.07
$71.50
Bioatla Inc Stock (BCAB) Company Profile
Firmenname
Bioatla Inc
Sektor
Branche
Telefon
858-558-0708
Adresse
11085 TORREYANA ROAD, SAN DIEGO
Compare BCAB vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
1.40 | 5.30M | 2.00M | -50.62M | -37.11M | -41.83 |
VRTX
Vertex Pharmaceuticals Inc
|
522.74 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
804.43 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,005.05 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.68 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.07 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Bioatla Inc Stock (BCAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2025-08-13 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-11-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-05-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-28 | Eingeleitet | ROTH Capital | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | BTIG Research | Buy |
| 2021-01-11 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-01-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Bioatla Inc Aktie (BCAB) Neueste Nachrichten
Bioatla Stock Price Forecast. Should You Buy BCAB? - StockInvest.us
BioAtla (BCAB) CMO has RSU shares withheld for taxes - Stock Titan
BioAtla (BCAB) CEO still holds 52,035 shares after tax withholding - Stock Titan
BioAtla (BCAB) CFO’s stock move is a tax withholding, not a sale - Stock Titan
BioAtla, Inc. Financial Disclosures & SEC Filings - TradingView
Book value per share of BioAtla, Inc. – OTC:BCAB - TradingView
BioAtla, Inc. Actuals & Estimates (OTC:BCAB) - TradingView
BioAtla, Inc.(NasdaqCM: BCAB) dropped from S&P TMI Index - marketscreener.com
Diluted shares outstanding of BioAtla, Inc. – OTC:BCAB - TradingView
Net current asset value per share of BioAtla, Inc. – OTC:BCAB - TradingView
Price to cash flow ratio of BioAtla, Inc. – OTC:BCAB - TradingView
Enterprise value to EBIT forward of BioAtla, Inc. – OTC:BCAB - TradingView
Enterprise value to EBITDA forward of BioAtla, Inc. – OTC:BCAB - TradingView
Enterprise value to EBITDA ratio of BioAtla, Inc. – OTC:BCAB - TradingView
EBITDA margin % of BioAtla, Inc. – OTC:BCAB - TradingView
Cost of goods sold of BioAtla, Inc. – OTC:BCAB - TradingView
Operating expenses (excl. COGS) of BioAtla, Inc. – OTC:BCAB - TradingView
Operating income of BioAtla, Inc. – OTC:BCAB - TradingView
Diluted earnings per share (diluted EPS) of BioAtla, Inc. – OTC:BCAB - TradingView
After tax other income/expense of BioAtla, Inc. – OTC:BCAB - TradingView
Cash flow from investing activities of BioAtla, Inc. – OTC:BCAB - TradingView
Cash flow from operating activities of BioAtla, Inc. – OTC:BCAB - TradingView
Average basic shares outstanding of BioAtla, Inc. – OTC:BCAB - TradingView
Free cash flow of BioAtla, Inc. – OTC:BCAB - TradingView
Non-controlling/minority interest of BioAtla, Inc. – OTC:BCAB - TradingView
Total revenue of BioAtla, Inc. – OTC:BCAB - TradingView
Cash flow from financing activities of BioAtla, Inc. – OTC:BCAB - TradingView
Gross profit of BioAtla, Inc. – OTC:BCAB - TradingView
Net income before discontinued operations of BioAtla, Inc. – OTC:BCAB - TradingView
Dilution adjustment of BioAtla, Inc. – OTC:BCAB - TradingView
Non-operating income (total) of BioAtla, Inc. – OTC:BCAB - TradingView
Total debt of BioAtla, Inc. – OTC:BCAB - TradingView
BioAtla, Inc. Cash Flow – OTC:BCAB - TradingView
Total equity of BioAtla, Inc. – OTC:BCAB - TradingView
Net debt of BioAtla, Inc. – OTC:BCAB - TradingView
BioAtla, Inc. Statistics – OTC:BCAB - TradingView
BioAtla, Inc. Balance Sheet – OTC:BCAB - TradingView
BioAtla, Inc. Earnings and Revenue – OTC:BCAB - TradingView
BioAtla, Inc. Revenue Breakdown – OTC:BCAB - TradingView
Net income of BioAtla, Inc. – OTC:BCAB - TradingView
BioAtla, Inc. Financial Statements – OTC:BCAB - TradingView
ETFs Investing in BioAtla, Inc. Stocks - TradingView
BioAtla, Inc. Income Statement – OTC:BCAB - TradingView
Free float of BioAtla, Inc. – OTC:BCAB - TradingView
Price to earnings ratio of BioAtla, Inc. – OTC:BCAB - TradingView
Basic earnings per share (basic EPS) of BioAtla, Inc. – OTC:BCAB - TradingView
BCAB Stock Price and Chart — OTC:BCAB - TradingView
BioAtla (BCAB) Holds Steady at $1.74 as Biotech Stock Consolidates Between Key LevelsHedge Fund Favorites - vinanet.vn
BCAB Q4 2025 Earnings: Narrower-Than-Expected Loss Fails to Halt 44.75% SlideEarnings Outlook Update - vinanet.vn
BioAtla Faces Nasdaq Delisting After Losing Final Appeal - Minichart
BioAtla Faces Nasdaq Delisting, Plans OTC Market Move - TipRanks
Finanzdaten der Bioatla Inc-Aktie (BCAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.63%
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):